Podchaser Logo
Home
144 - Aimovig for migraine; lofexidine for opioid withdrawal; 3-D printing 510(k) clearance; Gottleib statement on branded drug companies blocking generics

144 - Aimovig for migraine; lofexidine for opioid withdrawal; 3-D printing 510(k) clearance; Gottleib statement on branded drug companies blocking generics

Released Friday, 18th May 2018
Good episode? Give it some love!
144 - Aimovig for migraine; lofexidine for opioid withdrawal; 3-D printing 510(k) clearance; Gottleib statement on branded drug companies blocking generics

144 - Aimovig for migraine; lofexidine for opioid withdrawal; 3-D printing 510(k) clearance; Gottleib statement on branded drug companies blocking generics

144 - Aimovig for migraine; lofexidine for opioid withdrawal; 3-D printing 510(k) clearance; Gottleib statement on branded drug companies blocking generics

144 - Aimovig for migraine; lofexidine for opioid withdrawal; 3-D printing 510(k) clearance; Gottleib statement on branded drug companies blocking generics

Friday, 18th May 2018
Good episode? Give it some love!
Rate Episode

May 18, 2018

Please subscribe, rate and review if you like this podcast. Thank you! The podcast website is http://newfdaapprovals.com 

1:03 FDA approves novel preventive treatment for migraine https://www.prnewswire.com/news-releases/fda-approves-novel-preventive-treatment-for-migraine-300650782.html

2:44 FDA approves LUCEMYRA™ (lofexidine) after priority review for the management of opioid withdrawal symptoms https://www.prnewswire.com/news-releases/fda-approves-us-worldmeds-lucemyra-lofexidine-after-priority-review-for-the-management-of-opioid-withdrawal-symptoms-300649939.html https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm607884.htm

4:55 FDA clears patient specific 3D printed bone segments for the global extremities market

https://www.prnewswire.com/news-releases/additive-orthopaedics-announces-fda-clearance-of-their-patient-specific-3d-printed-bone-segments-for-the-global-extremities-market-300649830.html

5:45 Statement from FDA Commissioner Scott Gottlieb, M.D., on new agency efforts to shine light on situations where drug makers may be pursuing gaming tactics to delay generic competition

https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm607930.htm

Brought to you by Nascent Medical. For assistance with medical writing, please email [email protected].

Udemy course Freelance Medical Writing as a Career Choice. This is a 35-minute course giving an overview of what qualifications are needed, what skills and attributes are helpful and how much money you can make. https://www.udemy.com/freelance-medical-writing-career/?couponCode=MEDICALWRITING

Music credit: freemusicarchive.org/music/MindsEye/Yellow_Taxi/

Show More
Rate

Join Podchaser to...

  • Rate podcasts and episodes
  • Follow podcasts and creators
  • Create podcast and episode lists
  • & much more

Episode Tags

Do you host or manage this podcast?
Claim and edit this page to your liking.
,

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features